全文获取类型
收费全文 | 190918篇 |
免费 | 36906篇 |
国内免费 | 1377篇 |
专业分类
耳鼻咽喉 | 3209篇 |
儿科学 | 5653篇 |
妇产科学 | 4499篇 |
基础医学 | 16243篇 |
口腔科学 | 6976篇 |
临床医学 | 35832篇 |
内科学 | 44250篇 |
皮肤病学 | 5008篇 |
神经病学 | 21030篇 |
特种医学 | 6400篇 |
外国民族医学 | 1篇 |
外科学 | 27395篇 |
综合类 | 1580篇 |
现状与发展 | 41篇 |
一般理论 | 68篇 |
预防医学 | 23087篇 |
眼科学 | 3767篇 |
药学 | 8651篇 |
中国医学 | 218篇 |
肿瘤学 | 15293篇 |
出版年
2024年 | 828篇 |
2023年 | 5666篇 |
2022年 | 2734篇 |
2021年 | 5531篇 |
2020年 | 6851篇 |
2019年 | 4263篇 |
2018年 | 9277篇 |
2017年 | 9158篇 |
2016年 | 9941篇 |
2015年 | 10281篇 |
2014年 | 13422篇 |
2013年 | 16145篇 |
2012年 | 9900篇 |
2011年 | 9659篇 |
2010年 | 10007篇 |
2009年 | 11934篇 |
2008年 | 8470篇 |
2007年 | 7528篇 |
2006年 | 8357篇 |
2005年 | 6570篇 |
2004年 | 5628篇 |
2003年 | 4957篇 |
2002年 | 4637篇 |
2001年 | 3548篇 |
2000年 | 2774篇 |
1999年 | 3371篇 |
1998年 | 2934篇 |
1997年 | 2614篇 |
1996年 | 2585篇 |
1995年 | 2322篇 |
1994年 | 1675篇 |
1993年 | 1507篇 |
1992年 | 2053篇 |
1991年 | 1837篇 |
1990年 | 1648篇 |
1989年 | 1643篇 |
1988年 | 1553篇 |
1987年 | 1405篇 |
1986年 | 1394篇 |
1985年 | 1256篇 |
1984年 | 1108篇 |
1983年 | 1004篇 |
1982年 | 727篇 |
1981年 | 608篇 |
1980年 | 516篇 |
1979年 | 684篇 |
1978年 | 646篇 |
1977年 | 523篇 |
1976年 | 493篇 |
1974年 | 534篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Jae Eun Choi Tyler Werbel Zhenping Wang Chia Chi Wu Tony L. Yaksh Anna Di Nardo 《Journal of dermatological science》2019,93(1):58-64
Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献5.
6.
7.
8.
9.
Harvey A. Siegal PhD ; Paul J. Draus PhD ; Robert G. Carlson PhD ; Russel S. Falck MA ; Jichuan Wang PhD 《The Journal of rural health》2006,22(2):169-173
CONTEXT: Although the nonmedical use of stimulant drugs such as cocaine and methamphetamine is increasingly common in many rural areas of the United States, little is known about the health beliefs of people who use these drugs. PURPOSE: This research describes illicit stimulant drug users' views on health and health-related concepts that may affect their utilization of health care services. METHODS: A respondent-driven sampling plan was used to recruit 249 not-in-treatment, nonmedical stimulant drug users who were residing in 3 rural counties in west central Ohio. A structured questionnaire administered by trained interviewers was used to collect information on a range of topics, including current drug use, self-reported health status, perceived need for substance abuse treatment, and beliefs about health and health services. FINDINGS: Participants reported using a wide variety of drugs nonmedically, some by injection. Alcohol and marijuana were the most commonly used drugs in the 30 days prior to the interview. Powder cocaine was used by 72.3% of the sample, crack by 68.3%, and methamphetamine by 29.7%. Fair or poor health status was reported by 41.3% of the participants. Only 20.9% of the sample felt they needed drug abuse treatment. Less than one third of the sample reported that they would feel comfortable talking to a physician about their drug use, and 65.1% said they preferred taking care of their problems without getting professional help. CONCLUSIONS: Stimulant drug users in rural Ohio are involved with a range of substances and hold health beliefs that may impede health services utilization. 相似文献
10.
Clinical decisions are often made with incomplete information, yet patient care decisions are made every day. Patients vary clinically, uncertainty exists in diagnostic and prognostic information, and many preventive and treatment alternatives have not been formally assessed for their effectiveness. Because scientific information will never answer all clinical questions, clinical decisions are partially based on probabilistic information.
This paper describes how to apply clinical decision making to diagnosing and managing dental caries and periodontal diseases. By using explicit information to quantify probabilities and outcomes, clinical decision making analyzes decisions made under uncertain conditions and the uncertain impact of clinical information.
Clinical decision making incorporates concepts for preventing, diagnosing and treating dental caries and periodontal diseases: risk assessment, evidence-based dentistry, and multiple oral health outcomes. This information can serve as a tool for clinicians to augment clinical judgment and expertise. 相似文献
This paper describes how to apply clinical decision making to diagnosing and managing dental caries and periodontal diseases. By using explicit information to quantify probabilities and outcomes, clinical decision making analyzes decisions made under uncertain conditions and the uncertain impact of clinical information.
Clinical decision making incorporates concepts for preventing, diagnosing and treating dental caries and periodontal diseases: risk assessment, evidence-based dentistry, and multiple oral health outcomes. This information can serve as a tool for clinicians to augment clinical judgment and expertise. 相似文献